Aaron Weaver

Chief Commercialization Officer at Molecule

Speaker

Aaron Weaver is Chief Commercial Officer at Molecule, a pioneer in the Decentralized Science (DeSci) movement, working to transform biomedical research through tokenized IP and community-driven biotech funding. At Molecule, he leads commercial strategy and ecosystem development, helping connect researchers, funders, and biotech DAOs to unlock new models for early-stage drug discovery.Before joining Molecule, Aaron was a Senior Partner at Apeiron Investments, where he focused on frontier technologies in biotech, longevity, and mental health. He has served on the boards of Rejuveron Life Sciences and Alto Neuroscience, and was Investment Director at Frontier Acquisition Corp, a NASDAQ-listed SPAC focused on longevity. His early career spans roles in investment banking at Credit Suisse and law at Allen & Overy LLP in London.